Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Horvath

Showing results (241-250 of 279) with videos related to

Pageof 28
Sort By:
Cancer Discovery|October 20, 2023
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human StudyWilliam K Kelly, Daniel C Danila, Chia-Chi Lin, et al.
Iscience|November 19, 2019
E6AP Promotes a Metastatic Phenotype in Prostate CancerCristina Gamell, Ivona Bandilovska, Twishi Gulati, et al.
Nature Communications|November 9, 2017
Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancerFátima Valdés-Mora, Cathryn M Gould, Yolanda Colino-Sanguino, et al.
Cancer Research|March 25, 2026
Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy-Naïve Localized Prostate CancerEva Apostolov, Daniel L Roden, Holly Holliday, et al.
Oncogene|September 5, 2003
Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancerSusan M Henshall, Daniel E H Afar, Krishan K Rasiah, et al.
Molecular Cancer Research : MCR|January 17, 2019
Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate CancerSeher Balaban, Zeyad D Nassar, Alison Y Zhang, et al.
Nature|August 31, 2022
African-specific molecular taxonomy of prostate cancerWeerachai Jaratlerdsiri, Jue Jiang, Tingting Gong, et al.
Translational Andrology and Urology|May 10, 2021
Whole blood <i>GRHL2</i> expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancerEdmond M Kwan, Heidi Fettke, Megan Crumbaker, et al.
Cancers|October 13, 2021
Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate CancerHui-Ming Lin, Nicole Yeung, Jordan F Hastings, et al.
European Urology Oncology|March 20, 2026
Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14)S Gillessen, K Gobat, R Cathomas, et al.
Pageof 28

Showing results (241-250 of 279) with videos related to

Sort By:
Pageof 28
Cancer Discovery|October 20, 2023
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human StudyWilliam K Kelly, Daniel C Danila, Chia-Chi Lin, et al.
Iscience|November 19, 2019
E6AP Promotes a Metastatic Phenotype in Prostate CancerCristina Gamell, Ivona Bandilovska, Twishi Gulati, et al.
Nature Communications|November 9, 2017
Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancerFátima Valdés-Mora, Cathryn M Gould, Yolanda Colino-Sanguino, et al.
Cancer Research|March 25, 2026
Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy-Naïve Localized Prostate CancerEva Apostolov, Daniel L Roden, Holly Holliday, et al.
Oncogene|September 5, 2003
Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancerSusan M Henshall, Daniel E H Afar, Krishan K Rasiah, et al.
Molecular Cancer Research : MCR|January 17, 2019
Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate CancerSeher Balaban, Zeyad D Nassar, Alison Y Zhang, et al.
Nature|August 31, 2022
African-specific molecular taxonomy of prostate cancerWeerachai Jaratlerdsiri, Jue Jiang, Tingting Gong, et al.
Translational Andrology and Urology|May 10, 2021
Whole blood <i>GRHL2</i> expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancerEdmond M Kwan, Heidi Fettke, Megan Crumbaker, et al.
Cancers|October 13, 2021
Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate CancerHui-Ming Lin, Nicole Yeung, Jordan F Hastings, et al.
European Urology Oncology|March 20, 2026
Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14)S Gillessen, K Gobat, R Cathomas, et al.
Pageof 28